Gabapentin Tablet
Product Images NDC 63629-8492

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8492). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph depicting mean pain score over eight weeks for two groups: placebo and gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain scores from 0 to 10. The graph is divided into a 4-week dose titration period and a 4-week fixed dose period, with gabapentin showing a decreasing mean pain score compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

A line chart depicting mean pain scores over seven weeks comparing placebo with gabapentin dosed at 1800 mg/day and 2400 mg/day. The x-axis represents time in weeks, including a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. The graph shows a decrease in mean pain score for patients taking gabapentin compared to placebo over time.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares response percentages between placebo (PBO) and Gabapentin (GBP) at different dosages in two studies, showing higher responder proportions for Gabapentin doses.*

FDA Label Image

Image-04 (Image 04)

An illustration showing a formula for calculating creatinine clearance (CLCr) using age, weight, serum creatinine, and a factor for female patients (0.85). This formula is often used for dose adjustment considerations in medical practice.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin, showing its molecular layout with distinct cyclic and amino acid components.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart depicting percentage difference on the vertical axis against daily dose in milligrams on the horizontal axis, with data points for doses of 600, 900, 1200, and 1800 mg. The chart compares three different studies labeled as Study a, Study b, and Study c, each represented by distinct square markers in black, gray, and white, respectively.*

FDA Label Image

Label (Lbl636298492)

Gabapentin Tablets, USP 600 mg oral tablet label showing the product name, strength 600 mg, NDC 63629-8492-1, and the quantity of 100 tablets. The label includes storage instructions, manufacturer information (Siegen Pharmaceuticals, Inc.), and is relabeled by Bryant Ranch Prepack, Inc. The BRP Pharmaceuticals logo is visible, along with barcodes and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.